长期间歇性高体积血过在严重的败血症休克中
Rodrigo A Sepúlveda1,2, Cristián Juanet1,2, Juan P Huidobro1,2
1Department of Nephrology, School of Medicine, Pontificia Universidad Católica de Chile, Red de Salud UC-Christus, Santiago, Chile.
The International journal of artificial organs
|February 25, 2026
概括
长期间歇性高容量血过 (HVHF) 可能有助于管理严重的败血性休克. 这种疗法通过支持血液动力学和调节免疫系统,显示出潜在的益处,特别是在女性和手术患者身上.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學.
- 重症监护室的重症监护室是重症监护室的重症监护室.
背景情况:
- 感染性休克是一种危及生命的疾病,需要先进的干预措施.
- 高体积血过 (HVHF) 在严重的败血性休克中被探索为血液动力学支持和免疫调节.
研究的目的:
- 评估严重败血性休克患者对HVHF的反应.
- 为了确定与这种患者队列中死亡率相关的因素.
主要方法:
- 对63名接受HVHF治疗的严重败血症休克患者进行了回顾性队列研究.
- 对患者人口统计,临床数据和结果的分析.
主要成果:
- 死亡率与男性性别,医疗病理,慢性重症,SOFA分数升高和高剂量的北上腺素有关.
- 手术后24小时内HVHF与较低的死亡率相关 (p=0.025).
- 实际死亡率 (73%) 低于SOFA得分预测的 (80%-90%).
结论:
- HVHF可能有助于治疗严重的败血症休克,特别是在女性和手术患者中.
- 该疗法提供血液动力学支持和免疫调节,可能改善预后.
- HVHF允许感染控制时间和更好的患者结果.
相关概念视频
Continuous Renal Replacement Therapy
1.3K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.3K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
283
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
283
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
283
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
283
Hemodialysis II: Procedure and Complications
1.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.2K
Hemodialysis I: Introduction
2.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.2K
Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442


